Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 779

1.

Barriers to HIV testing among men who have sex with men in India reached online: implications for interventions.

Patel VV, Dange A, Rawat S, Arnsten JH, Piña C, Golub SA, Pujari R, Trivedi A, Harrison-Quintana J, Mayer KH.

J Acquir Immune Defic Syndr. 2018 Apr 10. doi: 10.1097/QAI.0000000000001698. [Epub ahead of print] No abstract available.

PMID:
29649075
2.

Characteristics and Correlates of Tobacco Use in a Community Sample of Sexual Minority Men and Women: Implications for Smoking Cessation Program Development.

O'Cleirigh C, Elsesser SA, King D, Ehlinger PP, Bradford JB, Grasso C, Mayer KH.

LGBT Health. 2018 Apr;5(3):197-202. doi: 10.1089/lgbt.2016.0157. Epub 2018 Mar 14.

PMID:
29641316
3.

Transactional Sex and Preferences for Pre-Exposure Prophylaxis (PrEP) Administration Modalities Among Men Who Have Sex With Men (MSM).

Mgbako O, Park SH, Mayer KH, Schneider JA, Goedel WC, Hambrick HR, Duncan DT.

J Sex Res. 2018 Apr 10:1-9. doi: 10.1080/00224499.2018.1449190. [Epub ahead of print]

PMID:
29634362
4.

Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India.

Freedberg KA, Kumarasamy N, Borre ED, Ross EL, Mayer KH, Losina E, Swaminathan S Dr, Flanigan TP, Walensky RP.

AIDS Res Hum Retroviruses. 2018 Mar 12. doi: 10.1089/AID.2017.0258. [Epub ahead of print]

PMID:
29620932
5.

The cost-effectiveness and budgetary impact of a dolutegravir-based regimen as first-line treatment of HIV infection in India.

Zheng A, Kumarasamy N, Huang M, Paltiel AD, Mayer KH, Rewari BB, Walensky RP, Freedberg KA.

J Int AIDS Soc. 2018 Mar;21(3):e25085. doi: 10.1002/jia2.25085.

6.

Pretreatment loss to follow-up of tuberculosis patients in Chennai, India: a cohort study with implications for health systems strengthening.

Thomas BE, Subbaraman R, Sellappan S, Suresh C, Lavanya J, Lincy S, Raja AL, Javeed B, Kokila S, Arumugam S, Swaminathan S, Mayer KH.

BMC Infect Dis. 2018 Mar 27;18(1):142. doi: 10.1186/s12879-018-3039-3.

7.

Antiretroviral Therapy and Mortality in Rural South Africa: A Comparison of Causal Modeling Approaches.

Oldenburg CE, Seage GR, Tanser F, De Gruttola V, Mayer KH, Mimiaga MJ, Bor J, Bärnighausen T.

Am J Epidemiol. 2018 Mar 23. doi: 10.1093/aje/kwy065. [Epub ahead of print]

PMID:
29584868
8.

HIV Preexposure Prophylaxis: A Review.

Riddell J 4th, Amico KR, Mayer KH.

JAMA. 2018 Mar 27;319(12):1261-1268. doi: 10.1001/jama.2018.1917. Review.

PMID:
29584848
9.

Primary Care Provider Practices and Perceptions Regarding HPV Vaccination and Anal Cancer Screening at a Boston Community Health Center.

Apaydin KZ, Fontenot HB, Shtasel DL, Mayer KH, Keuroghlian AS.

J Community Health. 2018 Feb 26. doi: 10.1007/s10900-018-0486-0. [Epub ahead of print]

PMID:
29480339
10.

Correlates of Linkage to HIV Preexposure Prophylaxis Among HIV-Testing Clients.

Flash CA, Adegboyega OO, Yu X, Avalos C, Johnson S, Mayer KH, Giordano TP.

J Acquir Immune Defic Syndr. 2018 Apr 1;77(4):365-372. doi: 10.1097/QAI.0000000000001605.

PMID:
29474256
11.

Catalyst for good: in Memoriam Mathilde Krim.

Mayer KH.

J Int AIDS Soc. 2018 Feb;21(2). doi: 10.1002/jia2.25086. No abstract available.

12.

Facilitators and Barriers to Pre-Exposure Prophylaxis (PrEP) Use Among Black Individuals in the United States: Results from the National Survey on HIV in the Black Community (NSHBC).

Ojikutu BO, Bogart LM, Higgins-Biddle M, Dale SK, Allen W, Dominique T, Mayer KH.

AIDS Behav. 2018 Feb 21. doi: 10.1007/s10461-018-2067-8. [Epub ahead of print]

PMID:
29468493
13.

Genetic Variation of the Kinases That Phosphorylate Tenofovir and Emtricitabine in Peripheral Blood Mononuclear Cells.

Figueroa DB, Madeen EP, Tillotson J, Richardson P, Cottle L, McCauley M, Landovitz RJ, Andrade A, Hendrix CW, Mayer KH, Wilkin T, Gulick RM, Bumpus NN.

AIDS Res Hum Retroviruses. 2018 Mar 20. doi: 10.1089/AID.2017.0243. [Epub ahead of print]

PMID:
29455571
14.

Co-occurring psychosocial problems predict HIV status and increased health care costs and utilization among sexual minority men.

O'Cleirigh C, Pantalone DW, Batchelder AW, Hatzenbuehler ML, Marquez SM, Grasso C, Safren SA, Mayer KH.

J Behav Med. 2018 Feb 6. doi: 10.1007/s10865-018-9913-z. [Epub ahead of print]

PMID:
29411273
15.

Impact of early antiretroviral therapy eligibility on HIV acquisition: household-level evidence from rural South Africa.

Oldenburg CE, Bor J, Harling G, Tanser F, Mutevedzi T, Shahmanesh M, Seage GR, De Gruttola V, Mimiaga MJ, Mayer KH, Pillay D, Bärnighausen T.

AIDS. 2018 Mar 13;32(5):635-643. doi: 10.1097/QAD.0000000000001737.

16.

Temporal Fluctuations in Behavior, Perceived HIV Risk, and Willingness to Use Pre-Exposure Prophylaxis (PrEP).

Underhill K, Guthrie KM, Colleran C, Calabrese SK, Operario D, Mayer KH.

Arch Sex Behav. 2018 Jan 11. doi: 10.1007/s10508-017-1100-8. [Epub ahead of print]

PMID:
29327091
17.

Sex Venue-Based Network Analysis to Identify HIV Prevention Dissemination Targets for Men Who Have Sex with Men.

Patel RR, Luke DA, Proctor EK, Powderly WG, Chan PA, Mayer KH, Harrison LC, Dhand A.

LGBT Health. 2018 Jan;5(1):78-85. doi: 10.1089/lgbt.2017.0018.

18.

Sexually transmitted infections in the era of antiretroviral-based HIV prevention: Priorities for discovery research, implementation science, and community involvement.

Marrazzo JM, Dombrowski JC, Mayer KH.

PLoS Med. 2018 Jan 10;15(1):e1002485. doi: 10.1371/journal.pmed.1002485. eCollection 2018 Jan.

19.

Association between internalized stigma and depression among HIV-positive persons entering into care in Southern India.

Chan BT, Pradeep A, Prasad L, Murugesan V, Chandrasekaran E, Kumarasamy N, Mayer KH, Tsai AC.

J Glob Health. 2017 Dec;7(2):020403. doi: 10.7189/jogh.07.020403.

20.

Predictors of Longitudinal Trajectories of Alcohol Consumption in People with HIV.

Bilal U, McCaul ME, Crane HM, Mathews WC, Mayer KH, Geng E, Napravnik S, Cropsey KL, Mugavero MJ, Saag MS, Hutton H, Lau B, Chander G.

Alcohol Clin Exp Res. 2018 Mar;42(3):561-570. doi: 10.1111/acer.13583. Epub 2018 Jan 29.

PMID:
29265385
21.

Excess Clinical Comorbidity Among HIV-Infected Patients Accessing Primary Care in US Community Health Centers.

Mayer KH, Loo S, Crawford PM, Crane HM, Leo M, DenOuden P, Houlberg M, Schmidt M, Quach T, Ruhs S, Vandermeer M, Grasso C, McBurnie MA.

Public Health Rep. 2018 Jan/Feb;133(1):109-118. doi: 10.1177/0033354917748670. Epub 2017 Dec 20.

PMID:
29262289
22.

Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials.

Gilbert PB, Juraska M, deCamp AC, Karuna S, Edupuganti S, Mgodi N, Donnell DJ, Bentley C, Sista N, Andrew P, Isaacs A, Huang Y, Zhang L, Capparelli E, Kochar N, Wang J, Eshleman SH, Mayer KH, Magaret CA, Hural J, Kublin JG, Gray G, Montefiori DC, Gomez MM, Burns DN, McElrath J, Ledgerwood J, Graham BS, Mascola JR, Cohen M, Corey L.

Stat Commun Infect Dis. 2017 Jan;9(1). pii: 20160001. doi: 10.1515/scid-2016-0001. Epub 2017 Jun 6.

23.

Calabrese et al. Respond.

Calabrese SK, Underhill K, Mayer KH.

Am J Public Health. 2018 Jan;108(1):e1-e2. doi: 10.2105/AJPH.2017.304172. No abstract available.

PMID:
29211531
24.

Sociodemographic and Clinical Factors Associated With Increasing Bacterial Sexually Transmitted Infection Diagnoses in Men Who Have Sex With Men Accessing Care at a Boston Community Health Center (2005-2015).

Mayer KH, Maloney KM, Levine K, King D, Grasso C, Krakower DS, Rosenberg ES, Boswell SL.

Open Forum Infect Dis. 2017 Oct 8;4(4):ofx214. doi: 10.1093/ofid/ofx214. eCollection 2017 Fall.

25.

Factors Associated with Gender-Affirming Surgery and Age of Hormone Therapy Initiation Among Transgender Adults.

Beckwith N, Reisner SL, Zaslow S, Mayer KH, Keuroghlian AS.

Transgend Health. 2017 Oct 1;2(1):156-164. doi: 10.1089/trgh.2017.0028. eCollection 2017.

26.

A Closer Look at Racism and Heterosexism in Medical Students' Clinical Decision-Making Related to HIV Pre-Exposure Prophylaxis (PrEP): Implications for PrEP Education.

Calabrese SK, Earnshaw VA, Krakower DS, Underhill K, Vincent W, Magnus M, Hansen NB, Kershaw TS, Mayer KH, Betancourt JR, Dovidio JF.

AIDS Behav. 2018 Apr;22(4):1122-1138. doi: 10.1007/s10461-017-1979-z.

PMID:
29151200
27.

Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.

Mayer KH, Seaton KE, Huang Y, Grunenberg N, Isaacs A, Allen M, Ledgerwood JE, Frank I, Sobieszczyk ME, Baden LR, Rodriguez B, Van Tieu H, Tomaras GD, Deal A, Goodman D, Bailer RT, Ferrari G, Jensen R, Hural J, Graham BS, Mascola JR, Corey L, Montefiori DC; HVTN 104 Protocol Team; and the NIAID HIV Vaccine Trials Network.

PLoS Med. 2017 Nov 14;14(11):e1002435. doi: 10.1371/journal.pmed.1002435. eCollection 2017 Nov.

28.

Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men.

Carballo-Diéguez A, Giguere R, Dolezal C, Leu CS, Balán IC, Brown W 3rd, Rael C, Richardson BA, Piper JM, Bekker LG, Chariyalertsak S, Chitwarakorn A, Gonzales P, Holtz TH, Liu A, Mayer KH, Zorrilla CD, Lama JR, McGowan I, Cranston RD; MTN-017 Protocol Team.

AIDS Behav. 2017 Dec;21(12):3336-3345. doi: 10.1007/s10461-017-1969-1.

PMID:
29119473
29.

MSM at Highest Risk for HIV Acquisition Express Greatest Interest and Preference for Injectable Antiretroviral PrEP Compared to Daily, Oral Medication.

Biello KB, Mimiaga MJ, Santostefano CM, Novak DS, Mayer KH.

AIDS Behav. 2018 Apr;22(4):1158-1164. doi: 10.1007/s10461-017-1972-6.

PMID:
29119472
30.

Punto Seguro: A Randomized Controlled Pilot Using Conditional Economic Incentives to Reduce Sexually Transmitted Infection Risks in Mexico.

Galárraga O, Sosa-Rubí SG, Kuo C, Gozalo P, González A, Saavedra B, Gras-Allain N, Conde-Glez CJ, Olamendi-Portugal M, Mayer KH, Operario D.

AIDS Behav. 2017 Dec;21(12):3440-3456. doi: 10.1007/s10461-017-1960-x.

PMID:
29110216
31.

Financial Hardship, Condomless Anal Intercourse and HIV Risk Among Men Who Have Sex with Men.

Duncan DT, Park SH, Schneider JA, Al-Ajlouni YA, Goedel WC, Elbel B, Morganstein JG, Ransome Y, Mayer KH.

AIDS Behav. 2017 Dec;21(12):3478-3485. doi: 10.1007/s10461-017-1930-3.

PMID:
29101606
32.

Potential Healthcare Insurance and Provider Barriers to Pre-Exposure Prophylaxis Utilization Among Young Men Who Have Sex with Men.

Marks SJ, Merchant RC, Clark MA, Liu T, Rosenberger JG, Bauermeister J, Mayer KH.

AIDS Patient Care STDS. 2017 Nov;31(11):470-478. doi: 10.1089/apc.2017.0171.

PMID:
29087744
33.

Evolving Models and Ongoing Challenges for HIV Preexposure Prophylaxis Implementation in the United States.

Mayer KH, Chan PA, R Patel R, Flash CA, Krakower DS.

J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):119-127. doi: 10.1097/QAI.0000000000001579.

PMID:
29084044
34.

Poor sleep health and its association with mental health, substance use, and condomless anal intercourse among gay, bisexual, and other men who have sex with men.

Duncan DT, Goedel WC, Mayer KH, Safren SA, Palamar JJ, Hagen D, Jean-Louis G.

Sleep Health. 2016 Dec;2(4):316-321. doi: 10.1016/j.sleh.2016.07.003. Epub 2016 Sep 5.

35.

Considerable interest in pre-exposure prophylaxis uptake among men who have sex with men recruited from a popular geosocial-networking smartphone application in London.

Goedel WC, Mayer KH, Mimiaga MJ, Duncan DT.

Glob Public Health. 2017 Oct 23:1-10. doi: 10.1080/17441692.2017.1391859. [Epub ahead of print]

PMID:
29058524
36.

Integrating HIV Preexposure Prophylaxis (PrEP) Into Routine Preventive Health Care to Avoid Exacerbating Disparities.

Calabrese SK, Krakower DS, Mayer KH.

Am J Public Health. 2017 Dec;107(12):1883-1889. doi: 10.2105/AJPH.2017.304061. Epub 2017 Oct 19.

PMID:
29048955
37.

Top Questions in ID: Pre-exposure Prophylaxis for HIV.

Krakower DS, Cohen SE, Mayer KH.

Open Forum Infect Dis. 2017 Aug 25;4(4):ofx185. doi: 10.1093/ofid/ofx185. eCollection 2017 Fall.

38.

Pre-exposure prophylaxis for MSM and transgender persons in early adopting countries.

Hoornenborg E, Krakower DS, Prins M, Mayer KH.

AIDS. 2017 Oct 23;31(16):2179-2191. doi: 10.1097/QAD.0000000000001627.

PMID:
28991023
39.

Discordance of voluntary HIV testing with HIV sexual risk-taking and self-perceived HIV infection risk among social media-using black, Hispanic, and white young-men-who-have-sex-with-men (YMSM).

Alexovitz KA, Merchant RC, Clark MA, Liu T, Rosenberger JG, Bauermeister J, Mayer KH.

AIDS Care. 2018 Jan;30(1):81-85. doi: 10.1080/09540121.2017.1381327. Epub 2017 Sep 29.

PMID:
28959902
40.

Markers of Microbial Translocation and Immune Activation Predict Cognitive Processing Speed in Heavy-Drinking Men Living with HIV.

Monnig MA, Kahler CW, Cioe PA, Monti PM, Mayer KH, Pantalone DW, Cohen RA, Ramratnam B.

Microorganisms. 2017 Sep 21;5(4). pii: E64. doi: 10.3390/microorganisms5040064.

41.

Preferences for Injectable PrEP Among Young U.S. Cisgender Men and Transgender Women and Men Who Have Sex with Men.

Biello KB, Hosek S, Drucker MT, Belzer M, Mimiaga MJ, Marrow E, Coffey-Esquivel J, Brothers J, Mayer KH.

Arch Sex Behav. 2017 Sep 19. doi: 10.1007/s10508-017-1049-7. [Epub ahead of print]

PMID:
28929260
42.

Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.

Hosek SG, Landovitz RJ, Kapogiannis B, Siberry GK, Rudy B, Rutledge B, Liu N, Harris DR, Mulligan K, Zimet G, Mayer KH, Anderson P, Kiser JJ, Lally M, Brothers J, Bojan K, Rooney J, Wilson CM.

JAMA Pediatr. 2017 Nov 1;171(11):1063-1071. doi: 10.1001/jamapediatrics.2017.2007.

PMID:
28873128
43.

Negotiating sexual safety in the era of biomedical HIV prevention: relationship dynamics among male couples using pre-exposure prophylaxis.

Malone J, Syvertsen JL, Johnson BE, Mimiaga MJ, Mayer KH, Bazzi AR.

Cult Health Sex. 2017 Sep 5:1-15. doi: 10.1080/13691058.2017.1368711. [Epub ahead of print]

PMID:
28872441
44.

Optimism and concern at IAS 2017.

Mayer KH.

Lancet HIV. 2017 Sep;4(9):e382-e383. doi: 10.1016/S2352-3018(17)30158-3. No abstract available.

PMID:
28865609
45.

A Pilot Randomized Controlled Trial of an Integrated In-person and Mobile Phone Delivered Counseling and Text Messaging Intervention to Reduce HIV Transmission Risk among Male Sex Workers in Chennai, India.

Mimiaga MJ, Thomas B, Biello K, Johnson BE, Swaminathan S, Navakodi P, Balaguru S, Dhanalakshmi A, Closson EF, Menon S, O'Cleirigh C, Mayer KH, Safren SA.

AIDS Behav. 2017 Nov;21(11):3172-3181. doi: 10.1007/s10461-017-1884-5.

PMID:
28831618
46.

Exploring strategies for PrEP adherence and dosing preferences in the context of sexualized recreational drug use among MSM: a qualitative study.

Closson EF, Mitty JA, Malone J, Mayer KH, Mimiaga MJ.

AIDS Care. 2018 Feb;30(2):191-198. doi: 10.1080/09540121.2017.1360992. Epub 2017 Aug 22.

PMID:
28830220
47.

Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial.

Gulick RM, Wilkin TJ, Chen YQ, Landovitz RJ, Amico KR, Young AM, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, McGowan I, Cottle LM, Andrade A, Marcus C, Klingman KL, Chege W, Rinehart AR, Rooney JF, Andrew P, Salata RA, Siegel M, Manabe YC, Frank I, Ho K, Santana J, Stekler JD, Swaminathan S, McCauley M, Hodder S, Mayer KH.

Ann Intern Med. 2017 Sep 19;167(6):384-393. doi: 10.7326/M17-0520. Epub 2017 Aug 22.

48.

Factors Supporting and Hindering Adherence to Rectal Microbicide Gel Use with Receptive Anal Intercourse in a Phase 2 Trial.

Giguere R, Rael CT, Sheinfil A, Balán IC, Brown W 3rd, Ho T, Dolezal C, Leu CS, Liu A, Mayer KH, Lama JR, McGowan I, Carballo-Diéguez A, Cranston RD; MTN-017 Protocol Team.

AIDS Behav. 2018 Feb;22(2):388-401. doi: 10.1007/s10461-017-1890-7.

PMID:
28825142
49.

HIV Preexposure Prophylaxis and Condomless Sex: Disentangling Personal Values From Public Health Priorities.

Calabrese SK, Underhill K, Mayer KH.

Am J Public Health. 2017 Oct;107(10):1572-1576. doi: 10.2105/AJPH.2017.303966. Epub 2017 Aug 17.

PMID:
28817325
50.

Tuberculosis patients in an Indian mega-city: Where do they live and where are they diagnosed?

Subbaraman R, Thomas BE, Sellappan S, Suresh C, Jayabal L, Lincy S, Raja AL, McFall A, Solomon SS, Mayer KH, Swaminathan S.

PLoS One. 2017 Aug 15;12(8):e0183240. doi: 10.1371/journal.pone.0183240. eCollection 2017.

Supplemental Content

Loading ...
Support Center